EUVIMEDUpptäck EUVIMED
Open access · CC BY 4.0

Craniofacial dysmorphology in Down syndrome is caused by increased dosage of Dyrk1a and at least three other genes

Yushi Redhead, Dorota Gibbins, Eva Lana-Elola, Sheona Watson-Scales, Lisa Dobson, Matthias Krause iD, Karen J Liu iD, Elizabeth M C Fisher iD, Jeremy B A Green iD, Victor L J Tybulewicz iD

Development · 2023-04-15 · 150 (8)

DOI: 10.1242/dev.201077 ↗

At a glance

Journal article in Development, published online on 2023-04-26. Written by Yushi Redhead and 9 co-authors. Institution: Centre for Craniofacial Biology and Regenerative Biology, King's College London, London SE1 9RT, UK. Major MEDLINE topics: Down Syndrome. Cited 34 times so far (Crossref); 74 references. The full text is freely available (open access, CC BY 4.0). Funded by: Wellcome Trust, Medical Research Council, Biotechnology and Biological Sciences Research Council.

AbstractSubjectsBibliografiska uppgifterCiteRelated studies

Abstract (original language)

Down syndrome (DS), trisomy of human chromosome 21 (Hsa21), occurs in 1 in 800 live births and is the most common human aneuploidy. DS results in multiple phenotypes, including craniofacial dysmorphology, which is characterised by midfacial hypoplasia, brachycephaly and micrognathia. The genetic and developmental causes of this are poorly understood. Using morphometric analysis of the Dp1Tyb mouse model of DS and an associated mouse genetic mapping panel, we demonstrate that four Hsa21-orthologous regions of mouse chromosome 16 contain dosage-sensitive genes that cause the DS craniofacial phenotype, and identify one of these causative genes as Dyrk1a. We show that the earliest and most severe defects in Dp1Tyb skulls are in bones of neural crest (NC) origin, and that mineralisation of the Dp1Tyb skull base synchondroses is aberrant. Furthermore, we show that increased dosage of Dyrk1a results in decreased NC cell proliferation and a decrease in size and cellularity of the NC-derived frontal bone primordia. Thus, DS craniofacial dysmorphology is caused by an increased dosage of Dyrk1a and at least three other genes.

Subjects

MeSH terms (MEDLINE)

Down SyndromeMiceHumansAnimalsSkullChromosome MappingPhenotypeDisease Models, Animal

Author keywords

Dyrk1aCraniofacial developmentDown syndromeMorphometricsNeural crestSynchondroses

Authors and institutions

  • Centre for Craniofacial Biology and Regenerative Biology, King's College London, London SE1 9RT, UK.
  • The Francis Crick Institute, London NW1 1AT, UK.
  • Randall Centre for Cell and Molecular Biophysics, King's College London, London SE1 1UL, UK.
  • Institute of Neurology, University College London, London WC1N 3BG, UK.

ORCID profiles: Matthias Krause, Karen J Liu, Elizabeth M C Fisher, Jeremy B A Green, Victor L J Tybulewicz

Funding

  • Wellcome Trust
  • Medical Research Council
  • Biotechnology and Biological Sciences Research Council

Cite

APA

Redhead, Y., Gibbins, D., Lana-Elola, E., Watson-Scales, S., Dobson, L., Krause, M., Liu, K. J., Fisher, E. M. C., Green, J. B. A., & Tybulewicz, V. L. J. (2023). Craniofacial dysmorphology in Down syndrome is caused by increased dosage of Dyrk1a and at least three other genes. Development, 150(8). https://doi.org/10.1242/dev.201077

Vancouver

Redhead Y, Gibbins D, Lana-Elola E, Watson-Scales S, Dobson L, Krause M, et al. Craniofacial dysmorphology in Down syndrome is caused by increased dosage of Dyrk1a and at least three other genes. Development. 2023;150(8). doi:10.1242/dev.201077

BibTeX
@article{Redhead2023,
  author = {Redhead, Yushi and Gibbins, Dorota and Lana-Elola, Eva and Watson-Scales, Sheona and Dobson, Lisa and Krause, Matthias and Liu, Karen J and Fisher, Elizabeth M C and Green, Jeremy B A and Tybulewicz, Victor L J},
  title = {Craniofacial dysmorphology in Down syndrome is caused by increased dosage of Dyrk1a and at least three other genes},
  journal = {Development},
  year = {2023},
  volume = {150},
  number = {8},
  doi = {10.1242/dev.201077}
}
Start for free →